Filing Details
- Accession Number:
- 0001209191-10-027953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-14 13:00:00
- Reporting Period:
- 2010-05-13
- Filing Date:
- 2010-05-14
- Accepted Time:
- 2010-05-14 16:14:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1108109 | Community Health Systems Inc | CYH | Services-General Medical & Surgical Hospitals, Nec (8062) | 133893191 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1018660 | T Wayne Smith | 4000 Meridian Boulevard Franklin TN 37067 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-05-13 | 243,093 | $20.30 | 1,092,472 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-13 | 243,093 | $41.02 | 849,379 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-05-14 | 6,907 | $20.30 | 856,286 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-05-14 | 6,907 | $40.50 | 849,379 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2010-05-13 | 243,093 | $0.00 | 243,093 | $20.30 |
Common Stock | Stock Options (Right to Buy) | Disposition | 2010-05-14 | 6,907 | $0.00 | 6,907 | $20.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
506,907 | 2004-05-22 | 2013-05-22 | No | 4 | M | Direct |
500,000 | 2004-05-22 | 2013-05-22 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,000 | Indirect | Spouse |
Common Stock | 79,750 | Indirect | by 2009 GRAT |
Common Stock | 200,000 | Indirect | by 2010 GRAT |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Performance Based Restricted | $0.00 | 200,000 | 200,000 | Direct | ||
Common Stock | Stock Options (Right to Buy) | $33.90 | 2011-02-24 | 2020-02-24 | 50,000 | 50,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $20.30 | 2004-05-22 | 2013-05-22 | 500,000 | 500,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $32.37 | 2006-02-28 | 2013-02-28 | 100,000 | 100,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $38.30 | 2007-03-01 | 2014-03-01 | 100,000 | 100,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $37.21 | 2008-02-28 | 2015-02-28 | 100,000 | 100,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $32.28 | 2009-02-27 | 2018-02-26 | 200,000 | 200,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $40.41 | 2008-07-25 | 2015-07-25 | 500,000 | 500,000 | Direct |
Common Stock | Stock Options (Right to Buy) | $18.18 | 2010-02-25 | 2019-02-25 | 50,000 | 50,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
200,000 | 200,000 | Direct | |
2020-02-24 | 50,000 | 50,000 | Direct |
2013-05-22 | 500,000 | 500,000 | Direct |
2013-02-28 | 100,000 | 100,000 | Direct |
2014-03-01 | 100,000 | 100,000 | Direct |
2015-02-28 | 100,000 | 100,000 | Direct |
2018-02-26 | 200,000 | 200,000 | Direct |
2015-07-25 | 500,000 | 500,000 | Direct |
2019-02-25 | 50,000 | 50,000 | Direct |
Footnotes
- These shares were sold in a series of transactions at an average sales price of $41.021 per share.
- These shares were sold in a series of transactions at an average sales price of $40.50 per share.
- Each performance based restricted share represents a contingent right to receive one share of CYH common stock. There are two elements to the lapsing of the restriction; first, the Company must achieve specified targeted amount of earnings per share from continuing operations, or net revenue from continuing operations, and if the performance objective is met, the vesting restrictions will lapse in 1/3 increments on the first, second and third anniversary of the date of grant. If the objectives are not met, the shares will be forfeited.